Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7203458, 8 pages
https://doi.org/10.1155/2017/7203458
Research Article

Tyrosine Phosphorylation of NR2B Contributes to Chronic Migraines via Increased Expression of CGRP in Rats

1Chongqing Cancer Institute & Hospital & Cancer Center, Chongqing, China
2Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
3Chongqing Key Laboratory of Neurology, Chongqing, China
4Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, USA

Correspondence should be addressed to Lixue Chen; nc.ude.umqc.latipsoh@euxilnehc

Received 18 October 2016; Revised 14 December 2016; Accepted 8 February 2017; Published 14 March 2017

Academic Editor: Gang Chen

Copyright © 2017 Xiping Liang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Headache Classification Subcommittee of the International Headache Society, “The International Classification of Headache Disorders: 2nd edition,” Cephalalgia, vol. 24, supplement 1, pp. 9–160, 2004. View at Google Scholar
  2. F. J. Carod-Artal, P. Irimia, and D. Ezpeleta, “Chronic migraine: definition, epidemiology, risk factors and treatment,” Revista de Neurologia, vol. 54, no. 10, pp. 629–637, 2012. View at Google Scholar · View at Scopus
  3. J. L. Natoli, A. Manack, B. Dean et al., “Global prevalence of chronic migraine: a systematic review,” Cephalalgia, vol. 30, no. 5, pp. 599–609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Bigal, A. M. Rapoport, R. B. Lipton, S. J. Tepper, and F. D. Sheftell, “Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) Questionnaire: a comparison of chronic migraine with episodic migraine,” Headache, vol. 43, no. 4, pp. 336–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Guy, A. R. Marques, T. Orliaguet, M. Lanteri-Minet, R. Dallel, and P. Clavelou, “Are there differences between cephalic and extracephalic cutaneous allodynia in migraine patients?” Cephalalgia, vol. 30, no. 7, pp. 881–886, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. Oshinsky and S. Gomonchareonsiri, “Episodic dural stimulation in awake rats: a model for recurrent headache,” Headache, vol. 47, no. 7, pp. 1026–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. L. Stucky, E. Gregory, M. K. Winter et al., “Sex differences in behavior and expression of cgrp-related genes in a rodent model of chronic migraine,” Headache, vol. 51, no. 5, pp. 674–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. X.-X. Qu, J. Cai, M.-J. Li et al., “Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain,” Experimental Neurology, vol. 215, no. 2, pp. 298–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Wong, I. Kang, X.-D. Dong et al., “NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors,” Neuroscience, vol. 269, no. 6, pp. 232–244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. S. Moon, M. L. Apperson, and M. B. Kennedy, “The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 9, pp. 3954–3958, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. L.-F. Lau and R. L. Huganir, “Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits,” Journal of Biological Chemistry, vol. 270, no. 34, pp. 20036–20041, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Qin, X. Fan, L. Chen et al., “Preventive effects of AdR-siPTEN through the regulation of NMDA receptor NR2B subunit in trigeminal ganglia of migraine rats,” Neurological Research, vol. 34, no. 10, pp. 998–1006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Monyer, R. Sprengel, R. Schoepfer et al., “Heteromeric NMDA receptors: molecular and functional distinction of subtypes,” Science, vol. 256, no. 5060, pp. 1217–1221, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Paoletti and J. Neyton, “NMDA receptor subunits: function and pharmacology,” Current Opinion in Pharmacology, vol. 7, no. 1, pp. 39–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. J. Woolf, “Central sensitization: implications for the diagnosis and treatment of pain,” Pain, vol. 152, no. 3, pp. S2–S15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Guo, S. Zou, Y. Guan et al., “Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia,” Journal of Neuroscience, vol. 22, no. 14, pp. 6208–6217, 2002. View at Google Scholar · View at Scopus
  17. M. L. Ramos-Romero and F. E. Sobrino-Mejia, “Calcitonin gene-related peptide: a key player neuropeptide in migraine,” Revista de Neurología, vol. 63, no. 16, pp. 460–468, 2016. View at Google Scholar
  18. B. Jacobs and G. Dussor, “Neurovascular contributions to migraine: moving beyond vasodilation,” Neuroscience, vol. 338, pp. 130–144, 2016. View at Google Scholar
  19. X. Liang, Q. Hu, B. Li et al., “Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats,” Stroke, vol. 45, no. 10, pp. 3048–3054, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Boyer, R. Dallel, A. Artola, and L. Monconduit, “General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression,” Pain, vol. 155, no. 7, pp. 1196–1205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Laurie, I. Bartke, R. Schoepfer, K. Naujoks, and P. H. Seeburg, “Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies,” Molecular Brain Research, vol. 51, no. 1-2, pp. 23–32, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Omote, K. Hazama, T. Kawamata et al., “Peripheral nitric oxide in carrageenan-induced inflammation,” Brain Research, vol. 912, no. 2, pp. 171–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Olesen, “The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache,” Pharmacology and Therapeutics, vol. 120, no. 2, pp. 157–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Jurado, M. Benoist, A. Lario, S. Knafo, C. N. Petrok, and J. A. Esteban, “PTEN is recruited to the postsynaptic terminal for NMDA receptor-dependent long-term depression,” The EMBO Journal, vol. 29, no. 16, pp. 2827–2840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. V. S. Seybold, “The role of peptides in central sensitization,” Handbook of Experimental Pharmacology, vol. 194, pp. 451–491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Hargreaves, “New migraine and pain research,” Headache, vol. 47, no. s1, pp. S26–S43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. L. Durham, “Diverse physiological roles of calcitonin gene-related peptide in migraine pathology: modulation of neuronal-glial-immune cells to promote peripheral and central sensitization,” Current Pain and Headache Reports, vol. 20, article 48, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. R. M. Van Dongen, R. Zielman, M. Noga et al., “Migraine biomarkers in cerebrospinal fluid: a systematic review and meta-analysis,” Cephalalgia, vol. 37, no. 1, pp. 49–63, 2017. View at Publisher · View at Google Scholar